Vital Therapies, Inc.
Quick facts
Phase 3 pipeline
- ELAD treatment · Hepatology / Critical Care
ELAD is an extracorporeal liver assist device that uses hepatocyte-based bioreactor technology to provide liver support and detoxification functions in patients with acute liver failure.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: